Search Results for ''

published presentations and documents on DocSlides.

by min-jolicoeur

Randomisation. Open-label. W8. * Liver biopsy or ...

C-WORTHY Study Part D: grazoprevir + elbasvir + RBV in genotype 3

C-WORTHY Study Part D: grazoprevir + elbasvir + RBV in genotype 3

by UnicornLove

C-WORTHY/D. GZR + EBR + RBV. GZR + EBR + RBV. N =...

by debby-jeon

SOF + RBV. Randomisation*. 1 : 1 : 1. Open-label....

by test

PTV150/r + OBV + . DSV . + RBV. PTV150/r + . DSV...

by pasty-toler

Design. C-SCAPE . Study. : . grazoprevir. ± . e...

Hepatitis C Drug Pipeline

Hepatitis C Drug Pipeline

by cheryl-pisano

HCV WORLD CAB .  FEBRUARY 2014. BANGKOK, THAI...

by tawny-fly

Design. C-SCAPE . Study. : . grazoprevir. ± . e...

C-WORTHY Study Part

C-WORTHY Study Part

by karlyn-bohler

D : . grazoprevir. . + . elbasvir. + RBV in ge...

by ellena-manuel

Feld JJ. NEJM . 2014;370:1594-1603. SAPPHIRE-I . ...

OBV/PTV/r DSV RBV OBV/PTV/r

OBV/PTV/r DSV RBV OBV/PTV/r

by ellena-manuel

DSV . placebo. Randomisation*. Partial blind. 1...

OBV/PTV/r DSV Open label

OBV/PTV/r DSV Open label

by kittie-lecroy

≥ 18 years. Chronic HCV infection. Genotype 1. ...

FISSION Design Objective

FISSION Design Objective

by travis

Non . inferiority. of SOF + RBV : SVR. 12. (. 2-...

by pamella-moone

*. 1:1. Open-label. ≥ 18 years. HCV genotype ...

by trish-goza

400/100 mg . qd. N = 120. N = 120. W12. SOF + RBV...

by celsa-spraggs

C-WORTHY Study Part C: . grazoprevir. . + . elba...

by tawny-fly

Placebo. LDV/SOF + placebo. Randomisation*. 1 : 1...

Future HCV Treatment Paradigms

Future HCV Treatment Paradigms

by kittie-lecroy

Mark Sulkowski, MD . Professor of Medicine. Medic...

Direct Acting Antivirals: What are they? What is their pl

Direct Acting Antivirals: What are they? What is their pl

by tawny-fly

Mark Sulkowski, MD. Associate Professor of Medici...

Reddy KR. Lancet Infect Dis. 2015;15:27-35

Reddy KR. Lancet Infect Dis. 2015;15:27-35

by natalia-silvester

ATTAIN. SMV + TVR placebo. + PEG-IFN + RBV. TVR ...

by pasty-toler

Hepatol. 2016; 64:19-28. MALACHITE. TVR + PEG-IF...

by myesha-ticknor

Hepatol. 2016; 64:19-28. MALACHITE. TVR + PEG-IF...

SMV 12W + PEG-IFN + RBV 24-48W **

SMV 12W + PEG-IFN + RBV 24-48W **

by alexa-scheidler

SMV 24W + PEG-IFN + RBV 24-48W **. Randomisation ...

by celsa-spraggs

N = 69. >. 18 years. Failure to SOF/VEL . or ...

by ellena-manuel

X. J . Hepatology. 2015; 63: 564-72. C-SALVAGE ...

by stefany-barnette

Randomisation*. Open-label. >. 18 years. HCV ...

by sherrill-nordquist

SOF + SMV + RBV. SOF + SMV. Randomisation. 2 : 1 ...

by pamella-moone

* Liver biopsy or . Fibroscan. ≤. 12.5 . kPa....

Hepatitis C Imtiaz Alam, M.D.

Hepatitis C Imtiaz Alam, M.D.

by olivia-moreira

Medical Director, Austin Hepatitis Center. 1. Hep...

Andrew J. Muir, MD, MHS Chief, Division of Gastroenterology

Andrew J. Muir, MD, MHS Chief, Division of Gastroenterology

by badra

Duke University School of Medicine. Durham, North ...

by kittie-lecroy

Paritaprevir. -. Ritonavir. . and . Dasabuvir. ...

by aaron

W24. DCV + PR. Placebo + PR. Yes. Dore GJ. Gastro...

Are Pan-Genotypic Therapies Ready for Prime Time?

Are Pan-Genotypic Therapies Ready for Prime Time?

by lois-ondreau

3. Rd. International . HIV/Hepatitis . Coinfecti...

by conchita-marotz

OBV/PTV/r + RBV. Randomisation*. 1 : 1. Open labe...

Not randomised Open-label

Not randomised Open-label

by cheryl-pisano

18-70 years. HCV genotype 1 or 3. Naïve or failu...

Boceprevir with PEG + RBV in Genotype 1

Boceprevir with PEG + RBV in Genotype 1

by caroline

SPRINT. -1. Phase . 2. Treatment. . Naïve. Kwo. ...

Paritaprevir-Ritonavir-Ombitasvir + Dasabuvir

Paritaprevir-Ritonavir-Ombitasvir + Dasabuvir

by vamput

Prepared by: . Sophie . Woolston. , MD and David H...

Daclatasvir Plus Sofosbuvir With or Without Ribavirin in Patients With HCV Genotype 3 Infection:

Daclatasvir Plus Sofosbuvir With or Without Ribavirin in Patients With HCV Genotype 3 Infection:

by kittie-lecroy

Interim Analysis of a French Multicenter Compassi...

Sofosbuvir + Peginterferon + Ribavirin in Genotype 2

Sofosbuvir + Peginterferon + Ribavirin in Genotype 2

by debby-jeon

. or 3 . LONESTAR-2. Phase 2. Treatment. . Exp...

by jane-oiler

N = 45. N = 49. W24. W16. MK3. > . 18 years. H...

No randomisation

No randomisation

by tatiana-dople

N = 100. W12. W24. Arm B: . compensated cirrhosis...